BIOTECH
BIOTECH
Body Vision Medical Closes New Funding Round to Accelerate Global Expansion of AI-Powered Intraoperative Imaging
Body Vision Medical, a global leader in AI-powered intraoperative imaging, has closed a new round...
Read moreBIOTECH
EBT Medical and NinaMED Announce US$13.75M Financing to Advance Licensed NiNA System® for Overactive Bladder
US$13.75M financing completed to accelerate clinical pathway and global commercialisation Establishment of NinaMED Pty Ltd,...
Read moreBIOTECH
Hope for Dry AMD: Novel Gene Therapy Completes First Human Safety Trial
Paris, France – April 23, 2026 – In a significant development for the millions suffering...
Read moreBIOTECH
Dosing completed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA)
Paris, France, January 22, 2026 – PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing...
Read moreBIOTECH
ErVimmune raises €17 million in Series A first closing to enter clinical development with lead cancer vaccine candidate
Next-generation therapeutic vaccines company also welcomes industry veteran Eric Halioua to board, as executive chairman....
Read more